Global Field Trials Advance AgroSpheres and FMC RNA Bioinsecticide Pipeline

The collaboration between AgroSpheres and FMC Corporation, initiated in 2024, focuses on developing targeted RNA-based biological crop protection agents. The current phase transitions two candidate molecules from greenhouse evaluation into multi-region field trials spanning the United States, Brazil, and Asia. These trials target lepidopteran pests, specifically species such as the fall armyworm (Spodoptera frugiperda) and the diamondback moth (Plutella xylostella), which account for significant annual economic losses in agricultural production systems globally.

Precision Delivery and Biomodality Mechanism
The technological foundation relies on two core proprietary systems developed by AgroSpheres: a biomodality platform and the AgriCell delivery architecture. The biomodality design creates sequence-specific RNA molecules that interfere with vital biological pathways in target pests via RNA interference (RNAi) mechanisms. This mode of action provides high target specificity, distinguishing it from conventional broad-spectrum chemical insecticides.

To overcome the inherent environmental instability of naked RNA molecules—which are typically vulnerable to ultraviolet photolysis, thermal degradation, and enzymatic breakdown—the AgriCell platform utilizes specialized encapsulation technology. This delivery matrix provides physical protection against environmental weathering factors such as heat and moisture, while engineering a controlled release profile. The encapsulation mechanism is designed to stabilize the active biomolecule post-application and facilitate compatibility with conventional tank-mix formulations and established crop protection chemistries.

Additional Context:
This section details technical specifications and competitive benchmarking not included in the original product announcement

RNA-based insecticides represent an emerging class of agricultural inputs positioned between conventional neurotoxic synthetic chemicals and traditional microbial biologicals (such as Bacillus thuringiensis).

Target Specificity and Resistance Management: Unlike broad-spectrum synthetic insecticides (e.g., organophosphates, pyrethroids, and neonicotinoids), RNAi-based bioinsecticides operate via sequence-specific gene silencing. This limits off-target toxicity to beneficial arthropods and pollinators, while offering a novel resistance-management tool to rotate with chemistries facing high resistance pressure.

Delivery and Field Persistence: A primary technical barrier in commercializing agricultural RNA interference has been rapid degradation in field environments. Traditional unprotected double-stranded RNA (dsRNA) exhibits a field half-life of typically less than 48 hours under solar ultraviolet exposure. Proprietary encapsulation systems, such as AgriCell, aim to extend residual activity metrics to match standard spray intervals required for commercial pest management.

Comparative Benchmarking: While large-scale commercial benchmarking data for multi-continent field trials remain proprietary, peer technologies in the agricultural RNAi space (such as those developed by GreenLight Biosciences or Corteva Agriscience) target similar lepidopteran thresholds. Objective performance criteria for these candidates require demonstrated field efficacy matching or exceeding standard synthetic control agents at equivalent application rates (measured in grams of active ingredient per hectare).

Edited by Sucithra Mani, Induportals editor – adapted by AI.

www.fmc.com